Recognition follows $100 million Tiffin expansion, resin manufacturing integration and continued investment in people, autonomous manufacturing, AI vision technology and innovative products

SARASOTA, Fla., Oct. 16, 2026 /PRNewswire/ -- Kreate, a product development and manufacturing company, announced it has been named The Home Depot's 2026 Partner of the Year, marking its third consecutive year receiving the recognition. The honor follows Kreate's $100 million expansion in Tiffin, Ohio, increased vertical integration into resin manufacturing and continued investment in its people, technology and HDX and Husky storage portfolio.

The Home Depot's annual Supplier Partnership and Innovation Awards recognize supplier partners that deliver value, innovation and performance for DIY and Pro customers. Kreate's recognition reflects a multi-year collaboration focused on expanding and improving The Home Depot's storage assortment through consumer-driven product development, advanced manufacturing, demand creation and dependable execution.

"Our people are our strength. This recognition belongs to the teams whose creativity, expertise and commitment make us a better partner every day," said Nickolas Reinhart, Founder and Owner of Kreate. "Our promise is simple: help our partners grow, win market share and serve their customers better. We do that by bringing innovative, exclusive products to market and investing in our people, autonomous manufacturing, AI vision technology and material science to improve quality and lower total landed cost. We want to deliver the best value, make working with us easy and earn the relationship through results every day."

People and Technology Working Together

Kreate combines the expertise of its people with robotics, automated material handling and AI-enabled machine vision to reduce defects, scrap and downtime while improving productivity, consistency and responsiveness.

The $100 million Tiffin expansion adds capacity and brings advanced production closer to customer demand. Kreate's strategically located manufacturing and distribution operations help reduce freight, handling and lead times while supporting reliable product availability.

Greater integration into resin manufacturing, supported by material science and engineering, enables Kreate to optimize formulations, product geometry and processing. These capabilities help reduce material cost and waste while maintaining the strength, durability and performance customers expect.

Kreate also evaluates the complete cost of delivering a dependable product, including materials, labor, tooling, energy, packaging, freight, inventory and quality. Resulting savings and performance improvements create greater value for partners and their customers.

Innovation That Helps Partners Grow

Kreate is on a mission to reimagine classes of products that better support the people who use them. The company combines extensive product, market, and manufacturing expertise with an ambitious, innovative spirit to turn "same old" into "new and improved."

Kreate designs, manufactures and distributes HDX and Husky storage and organization products available exclusively at The Home Depot. Its teams focus on customer needs, differentiated designs and complementary products that expand the storage ecosystem.

Recent innovations include:

- Tote Stacker: A storage solution that keeps totes organized and accessible, helping customers build more useful storage systems.

- HDX Defender Series: Waterproof and dustproof storage totes with integrated gaskets, heavy-duty latches and clear bins and lids for added protection and visibility. The 27-Gallon Defender Tote was named a 2026 Apartment Therapy Organization winner. Multiple modular sizes work together and integrate with the broader HDX storage ecosystem.

- HDX Vista Stack Series: A modular clear-storage system featuring stackable and nestable designs, secure latches and multiple sizes for clothing, bedding, seasonal décor and household essentials.

- HDX 2.5-Quart Mini Tough Tote: A compact addition to the HDX Tough Tote ecosystem, bringing the durability and modular design of larger totes to smaller items. Its snap lid and stackable, nestable construction support organization of tools, craft supplies, toys and other essentials.

- HDX Nano Tough Tote: A palm-sized, 0.75-quart addition to the HDX Tough Tote family, extending its heavy-duty storage design to hardware, craft supplies and other easily misplaced items.

Built Around the Partnership

Kreate aligns product development, capacity, capital investment and demand creation initiatives with its partners' customers, priorities and growth opportunities. The company emphasizes accountability, reliable delivery, proactive communication and continuous improvement across development, forecasting, ordering and support.

"Being the best partner takes more than a great product," Reinhart added. "It takes people who listen, take ownership and deliver what they promise. We will keep investing in those people and the technology that helps them succeed, keep creating exclusive advantages for our partners and keep finding better ways to serve the customer. That is how we grow together."

Kreate's award-winning products are available at The Home Depot online and in stores nationwide. For more information, visit storage.kreate.com.

About Kreate

Kreate is a product development and manufacturing company focused on reimagining product categories for today's consumers. From ideation to realization, Kreate combines the creativity and expertise of its people with engineering, material science, autonomous manufacturing and AI vision technology to develop differentiated products and bring better solutions to market. Its partner promise is to innovate, create exclusive advantages, lower total landed cost, deliver reliably and make the customer experience easy.

About Nickolas Asset Management

Nickolas Asset Management (NAM) is an evergreen, operator-led family office built on permanent capital and a long-term ownership philosophy. NAM partners with management teams to strengthen essential businesses by investing in people, technology and processes that support better products and sustainable growth.

Media Contact

[email protected]

SOURCE Kreate

Share this article

The article outlines key factors that influence cost, efficiency, and long-term home comfort.

TRAVERSE CITY, Mich., Nov. 20, 2026 /PRNewswire/ -- What should homeowners consider first when deciding between repair vs replace HVAC systems? The answer is explored in a HelloNation article that offers guidance and features insights from HVAC Expert Leslie Roe of Precision Plumbing and Heating Systems in Traverse City, Michigan.

The HelloNation article explains that HVAC system age is one of the most important factors in the repair-versus-replace decision. Systems typically last 10 to 15 years, and as HVAC systems age, the likelihood of costly breakdowns increases. The article notes that when a unit nears the end of its expected lifespan, replacement may offer more value than repeated furnace repair or temporary fixes.

Maintenance history also plays a central role in evaluating repair vs replace HVAC options. The article describes how a consistent maintenance history often leads to better performance and fewer disruptions. In contrast, poor maintenance history can lead to recurring HVAC issues that drive up repair costs over time. HVAC Expert Leslie Roe emphasizes in the article that recurring HVAC issues often signal that replacement should be considered more seriously.

The article also examines the type and severity of system problems. Minor issues, such as thermostat malfunctions or small leaks, may require only furnace repair or targeted service. However, multiple component failures and recurring HVAC issues often point to a system that can no longer operate efficiently. In these cases, the article explains that repair may provide only short-term relief, while AC replacement may offer a more stable long-term solution.

Energy use is another major factor discussed in the article. Older systems tend to lack modern heating and cooling efficiency, leading to higher monthly utility costs. The article highlights that upgrading to an AC replacement can significantly improve heating and cooling efficiency while reducing strain on the system. Improved heating and cooling efficiency not only lowers expenses but also enhances year-round home comfort.

Comfort and performance are closely tied to system condition. The article notes that uneven temperatures, weak airflow, and frequent cycling can reduce home comfort and signal deeper system problems. HVAC Expert Leslie Roe explains in the article that maintaining home comfort is often easier with newer systems designed for consistent performance. While furnace repair may temporarily restore function, long-term home comfort is often improved by replacement when systems are outdated.

Budget considerations are also addressed in the HelloNation article. Repair costs are usually lower at first, making furnace repair an appealing short-term option. However, the article explains that repeated repairs tied to recurring HVAC issues can quickly add up. AC replacement requires a higher upfront investment, but it can reduce future expenses and improve heating and cooling efficiency over time.

The article concludes that evaluating HVAC system age, maintenance history, repair frequency, and overall home comfort helps homeowners make informed decisions. By carefully weighing repair vs replace HVAC options, homeowners can better manage costs and system reliability. Consulting a qualified HVAC Expert is recommended to assess current performance and provide a clear path forward based on individual needs.

Should You Repair or Replace Your HVAC System? What Homeowners Should Consider First features insights from Leslie Roe, an HVAC expert at Precision Plumbing and Heating in Traverse City, Michigan, on HelloNation.

About HelloNation

HelloNation is a premier media platform that connects readers with trusted professionals and businesses across various industries. Through its innovative "edvertising" approach that blends educational content with storytelling, HelloNation delivers expert-driven, good-news articles that inform, inspire, and empower. Covering topics from home improvement and health to business strategy and lifestyle, HelloNation highlights leaders making a meaningful impact in their communities.

SOURCE HelloNation

Share this article

ANAHEIM HILLS, Calif., Oct. 16, 2026 /PRNewswire/ -- Credit Union of Southern California (CU SoCal) has announced a limited-time Share Certificate offering 7% APY for a 7-month term. Available through December 31, 2026, the market-leading offer helps Members earn more on deposits from a minimum deposit of $500 to a maximum $7,000 in new funds without committing to a long term.

"We designed this certificate to give more Members access to an outstanding rate without requiring a large deposit or a long-term commitment," said Suzie Kisslan, Chief Operating Officer at CU SoCal. "It's a compelling opportunity for savers to put their money to work and earn a competitive return."

New Members can open their account online at CUSoCal.org, at any CU SoCal branch, or by calling its Member Care Center at 866.287.6225. The offer ends December 31, 2026.

About Credit Union of Southern California (CU SoCal)

Founded in 1954 as Whittier Area Schools Federal Credit Union, Credit Union of Southern California (CU SoCal) is a federally chartered credit union open to anyone who qualifies for Membership. Individuals may become Members through family or household relationships, employer partnerships, select educational institutions, residency or employment in Lake Havasu City, Arizona, or through a complimentary membership in a CU SoCal nonprofit partner association. CU SoCal remains a Member-owned, not-for-profit cooperative dedicated to helping Members build better lives through personalized financial services and support. CU SoCal has a superior five-star financial rating from BauerFinancial, holds more than $4 billion in assets, and serves more than 187,000 Members. For more information, visit CUSoCal.org.

SOURCE Credit Union of Southern California

Share this article

DUBAI, UAE, October 16, 2026 /PRNewswire/ -- Robo.ai Inc. (Nasdaq: AIIO) (the "Company"), a UAE-based, U.S.-listed company, today announced that, subject to shareholder approval, the Company will implement a 1 for 25 reverse stock split of all classes of the Company's ordinary shares, including the Class A ordinary shares and the publicly traded Class B ordinary shares, effective at 9:30 am, U.S. Eastern time, on November 6, 2026. Before the reverse stock split, there were 13,817,501 Class A ordinary shares and 222,116,290 Class B ordinary shares issued and outstanding. After the reverse stock split, there will be 552,701 Class A ordinary shares and 8,884,684 Class B ordinary shares issued and outstanding. The Company's Class B ordinary shares will begin trading on an adjusted basis giving effect to the reverse stock split at the opening of market, U.S. Eastern time, on November 6, 2026 under the existing ticker symbol "AIIO." The new CUSIP number of the Company's Class B ordinary shares will be G6693P130.

As a result of the reverse stock split, the trading price of the Class B ordinary shares is expected to increase proportionately after the effectiveness of the reverse stock split, although the Company can give no assurance that the trading price of the Class B ordinary shares after the reverse stock split will be equal to or greater than twenty-five (25) times the trading price before the reverse stock split.

The reverse stock split affects all shareholders uniformly and will not alter any shareholder's percentage interest in the Company's outstanding share capital, except for adjustments that may result from the treatment of fractional shares.

Outstanding Company options, warrants, and other applicable convertible securities will be proportionately adjusted in accordance with their respective terms. No fractional shares will be issued in connection with the reverse stock split. Shareholders otherwise entitled to receive a fractional ordinary share as a result of the reverse share split will receive a full ordinary share in lieu of such fractional ordinary share.

In connection with the proposed reverse stock split, the Company will hold an extraordinary general meeting of shareholders (the "EGM") at 8:30 am, U.S. Eastern Time (4:30 pm, Dubai local time) on October 26, 2026 at Meydan Grandstand, 6th floor, Meydan Road, Nad Al Sheba, Dubai, United Arab Emirates. Shareholders can also participate in the EGM, vote, and submit questions via live webcast by visiting www.proxydocs.com/aiio.

Holders of ordinary shares of record at the close of business on October 14, 2026 (the "Record Date") or their proxy holders are entitled to vote at the EGM or any adjournment or postponements thereof. As of the Record Date, each Class A ordinary share is entitled to twenty-five votes, and each Class B ordinary share is entitled to one vote.

At the EGM, the following resolutions will be considered and voted upon.

1. As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as an ordinary resolution:

1a. the share consolidation (the "Share Consolidation") at the ratio of twenty-five (25)-for-one (1), whereby every twenty five (25) existing issued and unissued Class A ordinary shares with a par value of US$0.002 each be consolidated into one (1) Class A ordinary share with a par value of US$0.05 (the "New Class A Ordinary Shares") and every twenty five (25) existing issued and unissued Class B ordinary shares with a par value of US$0.002 each be consolidated into one (1) Class B ordinary share with a par value of US$0.05 (the "New Class B Ordinary Shares," together with the New Class A Ordinary Shares, the "Consolidated Shares"), be effected from November 6, 2026, with such New Class A Ordinary Shares and New Class B Ordinary Shares ranking pari passu in all respects with each other and having the rights and privileges and be subject to the restrictions in respect of the Consolidated Shares contained in the articles of association of the Company; and

1b. immediately following the Share Consolidation becoming effective, the Company's authorized share capital be changed:

From: US$4,000,000 divided into 2,000,000,000 shares, comprising 250,000,000 Class A ordinary shares with a par value of US$0.002 each, and 1,750,000,000 Class B ordinary shares with a par value of US$0.002 each,

To: US$4,000,000 divided into 80,000,000 shares, comprising 10,000,000 Class A ordinary shares with a par value of US$0.05 each, and 70,000,000 Class B ordinary shares with a par value of US$0.05 each; and

1c. all fractional Consolidated Shares resulting from the Share Consolidation be disregarded and not be issued to the shareholders of the Company but all such fractional Consolidated Shares be aggregated and, if possible, sold for the benefit of the Company in such manner and on such terms as the board of directors (the "Directors") of the Company may think fit; and

1d. any one or more Directors, company secretary, and/or the registered office provider of the Company be and is/are hereby authorized to take such actions, do all such acts and things, and execute all such further documents or deeds as he/they may, in his/their absolute discretion, consider necessary, appropriate, desirable, or expedient for the purpose of, or in connection with, the implementation of or giving effect to or the completion of any matters relating to the Share Consolidation.

2. As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as an ordinary resolution:

2a. upon the Share Consolidation becoming effective, the authorized share capital of the Company be increased from US$4,000,000 divided into 80,000,000 shares, comprising 10,000,000 New Class A Ordinary Shares and 70,000,000 New Class B Ordinary Shares, to US$19,250,000 divided into 385,000,000 shares, comprising 35,000,000 New Class A Ordinary Shares and 350,000,000 New Class B Ordinary Shares, by the creation of an additional 25,000,000 New Class A Ordinary Shares and an additional 280,000,000 New Class B Ordinary Shares (the "Increase in Authorized Share Capital"), with each New Class A Ordinary Share and New Class B Ordinary Share having such rights and restrictions as set out in the Seventh M&A (as defined below); and

2b. any one Director, company secretary, and/or the registered office provider of the Company be and is/are authorized to do all such acts and things and execute all such documents that he/she considers necessary, desirable, or expedient for the purpose of, or in connection with, the implementation of and giving effect to the Increase in Authorized Share Capital.

3. As special business, to consider and, if thought fit, pass with or without amendments, the following resolutions as a special resolution:

3a. upon the Share Consolidation and the Increase in Authorized Share Capital becoming effective, the seventh amended and restated memorandum and articles of association of the Company (the "Seventh M&A"), in the form annexed hereto as Annex A, be and is hereby approved and adopted in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company; and

3b. any one Director, company secretary, and/or the registered office provider of the Company be and is/are hereby authorized to do all such acts and things, execute all such documents or deeds, and make all such arrangements that he/she shall, in his/her absolute discretion, deem necessary or expedient to give effect to the adoption of the Seventh M&A, including without limitation, attending to the necessary filings with the Registrar of Companies in the Cayman Islands.

In addition, the EGM may transact any other business properly brought before it.

The notice of the EGM sets forth more details about the resolutions to be submitted to shareholders of the Company for approval and other relevant information regarding the EGM and how to vote ordinary shares at the EGM.

INVESTORS AND SHAREHOLDERS ARE URGED TO READ CAREFULLY AND IN THEIR ENTIRETY THE MATERIALS FILED WITH OR FURNISHED TO THE U.S. SECURITIES AND EXCHANGE COMMISSION, AS THEY CONTAIN IMPORTANT INFORMATION ABOUT THE COMPANY, THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION, AND RELATED MATTERS.

About Robo.ai Inc.

Robo.ai Inc. (Nasdaq: AIIO), headquartered in Dubai, United Arab Emirates, is a Nasdaq-listed technology group building intelligent infrastructure across four platforms: artificial intelligence; robotics and smart mobility; advanced manufacturing; and digital assets and capital. Its industrial group, Alif Holding, is dedicated to building intelligent industries through the development, integration and manufacturing of AI systems, serving government, public sector and mission-critical domains. Through its subsidiary Neurovia AI, the Company develops AI software and visual data infrastructure. Quantum Core Capital ("QC Capital"), its AI-powered deep-tech holding and venture-building platform, incubates, invests in and operates businesses across artificial intelligence, robotics, digital infrastructure and the next-generation digital economy.

Forward-Looking Statements

This press release contains statements that may constitute "forward-looking" statements pursuant to the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by terminology such as "will," "expects," "anticipates," "aims," "future," "intends," "plans," "believes," "estimates," "targets," "likely to," "challenges," and similar statements. Robo.ai may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission (the "SEC"), in its annual report to shareholders, in press releases and other written materials, and in oral statements made by its officers, directors, or employees to third parties.

Omnicom Schedules Third Quarter 2026 Earnings Release and Conference Call

NEW YORK, Oct. 16, 2026 /PRNewswire/ -- Omnicom (NYSE: OMC) will publish its third quarter 2026 results on Thursday, October 22, 2026 after the New York Stock Exchange close of trading. The company will also host a conference call to review such financial results on Thursday, October 22, 2026, starting at 4:30 p.m. Eastern Time. A live webcast of the call will be available at Omnicom's investor relations website, investor.omc.com, along with the related earnings press release and slide presentation. A webcast replay will be made available after the call concludes.

About Omnicom

Omnicom (NYSE: OMC) is the world's leading marketing and sales company. Powered by Omni, its proprietary data and identity platform, Omnicom's Connected Capabilities unite the company's agency brands, talent, and domain expertise across media, commerce, consulting, precision marketing, advertising, production, health, public relations, branding, and experiential to address clients' most critical growth priorities. For more information, visit www.omc.com.

SOURCE Omnicom Group Inc.

Share this article

PITTSBURGH, Oct. 16, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the U.S. Food and Drug Administration (FDA) has approved RYZUMVI® (phentolamine ophthalmic solution 0.75%) for the treatment of presbyopia in adults. RYZUMVI is currently approved in the United States for the treatment of pharmacologically-induced mydriasis and is the only commercially available FDA-approved product for that use. This approval expands the product's indications to include presbyopia.

Viatris is exploring the potential for a partner in the United States to commercialize RYZUMVI for the treatment of presbyopia.

About Opus Genetics and Viatris Collaboration

Opus Genetics and Viatris Inc. (through an affiliated entity) are parties to a global licensing agreement which provides for the development of phentolamine ophthalmic solution 0.75% and grants exclusive rights to Viatris to commercialize the product in the United States.

About Presbyopia

Presbyopia is the gradual loss of near focusing ability due to aging, that typically becomes noticeable in the early to mid-40s. It is a nearly universal condition that, when uncorrected, contributes significantly to vision-related disability. Presbyopia leads to symptoms like eye strain and blurred near vision, impacting daily tasks and productivity.

INDICATIONS AND USAGE

RYZUMVI® (phentolamine ophthalmic solution) 0.75% is indicated for:

- Treatment of presbyopia in adults

- Treatment of pharmacologically-induced mydriasis produced by adrenergic agonists (e.g., phenylephrine) or parasympatholytic agents (e.g., tropicamide) in adults and pediatric patients 3 years of age and older

IMPORTANT SAFETY INFORMATION

Warnings and Precautions

Uveitis: RYZUMVI is not recommended to be used in patients with active ocular inflammation (e.g., iritis).

Potential for Eye Injury or Contamination: To avoid the potential for eye injury or contamination, care should be taken to avoid touching the vial tip to the eye or to any other surface.

Use with Contact Lenses: Contact lens wearers should be advised to remove their lenses prior to the instillation of RYZUMVI and wait 10 minutes after dosing before reinserting their contact lenses.

Adverse Reactions

Presbyopia

The most common ocular adverse reactions reported in > 5% of subjects were conjunctival hyperemia (21%) and instillation site irritation (16%).

Pharmacologically-induced Mydriasis

The most common ocular adverse reactions reported in > 5% of subjects were instillation site discomfort including pain, stinging, and burning (16%) and conjunctival hyperemia (12%). The only non-ocular adverse reaction reported in > 5% of subjects was dysgeusia (6%). The majority of the adverse reactions were mild, transient and self-resolving.

Please see complete Prescribing Information

About Viatris

Viatris Inc. (Nasdaq: VTRS) is a global healthcare company whose mission is to empower people worldwide to live healthier at every stage of life. We meet the needs of patients around the world by acting decisively with ingenuity and resolve. Whether we're developing new medicines, working to maintain a resilient supply of needed therapies, or pursuing bold innovation, we strive to deliver solutions that are effective at scale and built to endure. We're purpose-built to make an impact with a broad portfolio that spans generics, value-added medicines, established brands, and innovative medicines that address areas of significant unmet need. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X.

Forward-Looking Statements

This press release includes statements that constitute "forward-looking statements." These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements may include statements about the approval of RYZUMVI® for the treatment of presbyopia in adults; and Viatris is exploring the potential for a partner in the United States to commercialize RYZUMVI for the treatment of presbyopia. Because forward-looking statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: failure to achieve the intended benefits of our strategic initiatives and priorities; goodwill or impairment charges or other losses; any changes in or difficulties with the Company's manufacturing facilities; failure to achieve expected or targeted future financial and operating performance and results; Viatris' or its partners' ability to develop, manufacture, and commercialize products; any regulatory, legal or other impediments to Viatris' ability to bring new products to market; products in development and/or that receive regulatory approval may not achieve expected levels of market acceptance, efficacy or safety; actions and decisions of healthcare and pharmaceutical regulators; changes in healthcare and pharmaceutical laws and regulations in the U.S. and abroad; the scope, timing and outcome of any ongoing legal proceedings, and the impact of any such proceedings on Viatris; any significant breach of data security or data privacy or disruptions to our IT systems; risks associated with international operations; changes in third-party relationships; the effect of any changes in Viatris' or its partners' customer and supplier relationships and customer purchasing patterns; the impacts of competition; changes in the economic and financial conditions of Viatris or its partners; uncertainties regarding future demand, pricing and reimbursement for the Company's products; uncertainties and matters beyond the control of management, including but not limited to general political and economic conditions, potential adverse impacts from future tariffs and trade restrictions, inflation rates and global exchange rates; and the other risks described in Viatris' filings with the Securities and Exchange Commission ("SEC"). Viatris routinely uses its website as a means of disclosing material information to the public in a broad, non-exclusionary manner for purposes of the SEC's Regulation Fair Disclosure (Reg FD). Viatris undertakes no obligation to update these statements for revisions or changes after the date of this press release other than as required by law.

SOURCE Viatris Inc.

Share this article

Five Stars. 10,000 Times. IVX Health Celebrates a Major Patient Experience Milestone.

National infusion provider surpasses 10,000 five-star Google reviews across its 160+ ambulatory infusion centers.

BRENTWOOD, Tenn., Oct. 16, 2026 /PRNewswire/ -- IVX Health, a national provider of outpatient infusion and injection therapy for individuals with complex chronic conditions, today announced it has earned 10,000 five-star Google reviews, as of October 13, 2026, across its national network—a milestone powered by the people receiving care and the teams delivering it.

Each five-star review represents someone choosing to give IVX Health Google's highest rating. Together, those 10,000 reviews offer a powerful expression of appreciation for a care experience built around comfort, compassion and personal attention.

"Ten thousand times, someone took a moment to give our team five stars. That is an extraordinary honor," said Doug Ghertner, CEO of IVX Health. "For our nurses and front desk coordinators in the clinic and all of the other IVXers that helped those patients get the care they need, this milestone recognizes the everyday moments that matter: a warm welcome, a question answered, a reassuring conversation and the confidence that someone is looking out for you."

For people managing complex chronic conditions, infusion therapy can become a recurring part of life. IVX Health designs its centers and services around making that experience more comfortable and convenient, with private patient suites, flexible scheduling, evening and weekend appointments, and experienced clinical teams.

That approach gives patients a welcoming place to receive treatment close to where they live and work. Comfortable recliners, personal televisions, complimentary Wi-Fi and snacks help patients settle in, while dedicated care teams support them throughout their visits.

The milestone also recognizes the employees whose work shapes the experience before, during and after treatment—from coordinating referrals and navigating insurance requirements to welcoming patients and administering care.

"Our patients have enough to manage. We want their time with us to be a part of their day they can feel good about," Ghertner said. "These 10,000 five-star reviews belong to the teams who bring that commitment to life, visit after visit. We are grateful to everyone who has shared their experience and trusted us with their care."

As IVX Health continues expanding access to outpatient infusion therapy, its focus remains personal: delivering thoughtful, attentive care to each patient who walks through its doors.

To learn more about IVX Health or request an appointment, visit www.ivxhealth.com/appointments

To refer a patient, visit www.ivxhealth.com/referrals

About IVX Health

IVX Health is a national provider of infusion and injection therapy for those across 45 complex chronic conditions such as rheumatoid arthritis, Crohn's disease, multiple sclerosis, autoimmune disease and other conditions.

IVX Health's national footprint of over 160 outpatient infusion centers are conveniently located in the communities where patients live and work. IVX Health's experience-first model includes amenities such as flexible appointment scheduling with evening and weekend availability, guaranteed private suites, high-speed Wi-Fi, flat screen TVs with streaming TV and movies, and comfortable recliners with room for guests. For more information on IVX Health and its existing locations, visit www.ivxhealth.com.

SOURCE IVX Health

Share this article

In the news release, Museum of Illusions to Open First Northern California Location, Bringing Mind-Bending Exhibits to Downtown Sacramento Starting November 6, issued 15-Oct-2026 by Museum of Illusions over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Museum of Illusions to Open First Northern California Location, Bringing Mind-Bending Exhibits to Downtown Sacramento Starting November 6

Downtown attraction brings interactive illusions to DOCO; tickets on sale October 15

SACRAMENTO, Calif., Oct. 15, 2026 /PRNewswire/ -- Museum of Illusions, the largest and fastest growing private museum with immersive rooms, stand-alone illusions, and holograms and prints designed to deceive the eye and bend perceptions, today announced it is reimagining reality in Northern California. The brand's newest location, Museum of Illusions Sacramento, will open its doors on November 6. Located at 405 K Street, Suite 110, the 10,000-square-foot museum is the brand's 72nd location worldwide, third location in California (joining Museum of Illusions San Diego and Santa Monica which opened in 2025) and first in the northern region of the state.

With a downtown address that draws locals, commuters and visitors alike, the museum gives Sacramento's Wonder Seekers a new place to gather, play and explore together. Museum of Illusions Sacramento combines entertainment and education in a format that sparks curiosity in visitors of every age. Hands-on exhibits invite guests to experience each illusion and discover the science behind how the eye and brain interpret what we see.

"Sacramento's history is full of illusions, from Gold Rush-era storefronts built to look grander than they were, to the promise of fortune that wasn't always what it seemed. This city is a natural fit for Museum of Illusions," said Kim Schaefer, CEO of Museum of Illusions. "This is a place where families, friends and coworkers can step inside an illusion together and leave with a story and a photo to match."

Rather than a one-size-fits-all experience, Museum of Illusions Sacramento was designed with the city's own history in mind, having several signature exhibits draw inspiration from Sacramento's Gold Rush roots. Guests can look forward to over 70 exhibits and attractions throughout the museum, including Building Illusion, Following Eyes and Reverse Room.

To celebrate the opening of the new location, Museum of Illusions Sacramento is giving guests two reasons to be among the first through the door. Through November 5, the Book Early Offer lets guests lock in buy-one-get-one-free tickets when they purchase through the ticket link HERE. Then, once the doors officially open, the Grand Opening Offer keeps the celebration going with 20% off tickets for the museum's first four weeks, from November 6 through December 4.

Museum of Illusions Sacramento is open Sunday through Thursday from 10 a.m. to 9 p.m. and Friday and Saturday from 10 a.m. to 10 p.m. General admission starts at $30 for adults and $26 for children ages 5-12. Illusion Experts are on hand to help Wonder Seekers and new guests capture the best photo at every exhibit and explain why exactly their eyes are being deceived.

Stay up to date on the latest news, exclusive promotions, special events, and thrilling experiences at the museum, be sure to follow along on Instagram and TikTok at @MuseumOfIllusions_USA, or by signing up for the MOI Insider newsletter.

About Museum of Illusions

Museum of Illusions is the largest and fastest-growing chain of private museums in the world. The unique concept offers all age groups an interactive experience where mind-blowing exhibits play tricks on the minds of visitors and show them the exciting science behind illusions. With over 70 locations across more than 30 countries, Museum of Illusions continues to grow and share the fascinating world of illusions with curious minds all over the world.

Media Contact

ICR x Blue Engine

[email protected] 

Correction: The address of the museum has been updated with the correct suite number.

SOURCE Museum of Illusions

Share this article

VANCOUVER, BC, Oct. 16, 2026 /PRNewswire/ -- Stock Preachers News Commentary - Wall Street closed a volatile week split sharply down the middle. The Dow finished Friday at 52,134.63, down 0.08% on the day but still up 0.93% for the week, while the Nasdaq Composite tumbled 1.28% Friday and 3.64% for the week, its worst stretch in months. The S&P 500 fell 1.43% weekly and the Russell 2000 dropped 2.43%. The VIX climbed to 17.02 and the VXN jumped to 22.89, underscoring the growing divide between mega-cap tech weakness and broader market resilience. Active Companies from around the markets with current developments this week include: Lockheed Martin (NYSE: LMT), Beretta Holding S.A. (NYSE: RGR), Truist Financial Corporation (NYSE: TFC), CLPS Incorporation (Nasdaq: CLPS), and Orvana Minerals Corp. (TSX: ORV).

Friday's session showed the market's split personality in real time. The S&P 500 slid 0.58% to 7,699.50, pulling back from its week high of 7,821.67 and testing its 50-day EMA support near 7,681.97. The Nasdaq's 1.28% Friday drop capped a week that erased nearly 1,000 points, closing at 26,370.53 against a week high of 27,376.66, with RSI14 down to 40.4, signaling fading momentum.

Small caps lagged further, with the Russell 2000 down 1.03% Friday and 2.43% on the week, closing at 2,738.83 with an RSI14 of just 33.5, deep in weaker territory. The Dow bucked the trend, holding a 0.93% weekly gain and an 8.47% year-to-date advance, closing just under resistance at 52,281.19 and above its 50-day EMA support at 52,017.10.

Commodities sent mixed signals too. Gold slipped 0.10% for the week to $4,186.50 an ounce while silver fell 4.38% to $57.51. WTI crude jumped 4.17% weekly to $97.65 a barrel, up 70.06% year-to-date, while the 10-year Treasury yield eased 13 basis points to 5.11%, even as it ticked up 2 basis points on the day.

The full report breaks down the key support and resistance levels traders are watching next week along with sector-by-sector sentiment across the divided market.

CONTINUED... Read this and more news at: https://stockpreachers.com/articles/a-week-that-split-the-market-right-down-the-middle/

In other industry developments and happenings in the market this week include:

Lockheed Martin (NYSE: LMT) Lockheed Martin delivered a C-130J-30 Super Hercules aircraft to the U.S. Navy at its Marietta, Georgia facility on Oct. 15, marking the start of its transformation into the E-130J Phoenix II, the Navy's next-generation TACAMO mission platform for airborne nuclear command and control.

The aircraft will next be transferred to Northrop Grumman, the mission systems integrator, to complete the conversion. "This delivery marks a historic milestone for the U.S. Navy, Lockheed Martin, and the nation's strategic communications network," said Trish Pagan, vice president of Lockheed Martin's Air Mobility & Maritime Missions.

The delivery revives the link between the TACAMO mission and the Hercules family, which previously flew the mission via the EC-130Q variant from 1963 until 1993.

Beretta Holding S.A. (NYSE: RGR) Beretta Holding announced preliminary results of its cash tender offer for shares of Sturm, Ruger & Company at $44.80 per share. The offer, which expired Oct. 15, sought up to 2,400,184 shares but drew 3,589,647 shares validly tendered, excluding 2,652,256 shares tendered by notice of guaranteed delivery.

Because the offer was oversubscribed, Beretta Holding estimates a preliminary proration factor of approximately 38.45%, subject to confirmation by the depositary following the guaranteed delivery period.

"This investment represents a significant milestone for Beretta Holding. It marks our first participation in a publicly listed company and opens a new chapter in our development as a long-term investor in the U.S. capital markets," said Pietro Gussalli Beretta, Chairman and CEO of Beretta Holding.

Truist Financial Corporation (NYSE: TFC) Truist Financial Corporation reported its third quarter 2026 results, with details available through its earnings release, investor presentation and Quarterly Performance Summary posted to the company's investor relations website.

The company hosted a live earnings call at 8 a.m. ET the same day, with a replay made available on its website for 30 days.

Truist describes itself as a top-10 commercial bank with total assets of $554 billion as of Sept. 30, 2026, offering consumer and small business banking, commercial and corporate banking, investment banking, wealth management, payments and specialized lending.

CLPS Incorporation (Nasdaq: CLPS) CLPS Incorporation reported full fiscal year 2026 revenue growth of 4.7% year-over-year to $172.2 million, and second-half revenue growth of 6.6% to $87.1 million, despite revenue pressure from the downsizing of a key client's China Solution Centers.

Revenue from customized IT solution services surged 113.9% year-over-year to $5.9 million for the full year, while revenue generated outside mainland China rose 47.5% to $62.7 million, with Hong Kong SAR up 61.0% to $23.2 million and Japan up 122.7% to $4.5 million.

"Fiscal 2026 was a pivotal year of structural transition and resilience for CLPS," said Raymond Lin, Chief Executive Officer of CLPS. "Since becoming a publicly traded company in 2018, we have expanded our topline from $48.9 million to $172.2 million, delivering a robust 17.0% compound annual growth rate over the past eight years."

Orvana Minerals Corp. (TSX: ORV) Orvana Minerals Corp. reported fourth quarter and fiscal 2026 production results, with consolidated FY2026 production of 45,160 gold equivalent ounces, comprised of 39,282 gold ounces, 3.1 million pounds of copper and 112,499 silver ounces.

Orovalle produced 37,775 ounces of gold and 2.9 million pounds of copper in FY2026, exceeding gold production guidance of 34,000 to 37,000 ounces and landing within copper guidance of 2,700 to 3,000 thousand pounds. EMIPA produced its first dore and copper cathodes from the expanded Don Mario Plant during the quarter but came in below the company's FY2026 guidance, which was withdrawn on September 17, 2026.

"Looking ahead to FY2027, our focus remains on sustaining disciplined production performance and operational efficiency while managing inflationary cost pressures arising from broader global conditions and continued workforce challenges."

Sign-up up free for timely articles like this delivered directly to your inbox at: https://StockPreachers.com

Contact Information:

Media Contact: [email protected]

DISCLAIMER: Nothing in this article should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a market commentary and is not a paid advertisement. This article is being distributed by Stock Preachers, which is wholly owned and operated by Market Equities Limited ("MEL"), a company incorporated under the laws of Ireland. Market Equities and its owners, operators, directors, and affiliates may, from time to time, hold positions in securities mentioned in this article or in the broad-market index funds that track them, and reserve the right to buy, sell, or hold such securities at any time without further notice. Information in this article was obtained from sources believed to be reliable, including company news releases and public market data, but its accuracy cannot be guaranteed. Market data is as of the time stated and may be delayed. Investing in securities involves risk, including the possible loss of some or all of your investment. Technical analysis describes past price and volume behaviour and does not predict future results; support and resistance levels can fail at any time. Nothing in this article is a recommendation to buy, sell, or hold any security. Quotations attributed to company executives are reproduced from those companies' own news releases. Forward-Looking Statements: This article may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements made by the companies mentioned in their own news releases. Such statements involve risks and uncertainties, and actual results may differ materially. Readers should review each company's filings with the SEC and applicable Canadian securities regulators.

SOURCE Stock Preachers

Share this article

Corgi Insurance Recognized on LinkedIn's 2026 Top Startups Annual List, Ranking No. 6 in San Francisco

SAN FRANCISCO, Oct. 16, 2026 /PRNewswire/ -- Corgi Insurance has been recognized on LinkedIn's 2026 Top Startups lists, ranking No. 16 among the 50 top startups in the United States and No. 6 in San Francisco. The recognition highlights the company's growth and momentum as it builds modern commercial insurance for startups and small businesses.

LinkedIn's annual Top Startups rankings use platform data to assess signals including employee growth, jobseeker interest and the ability to attract talent from leading companies. Corgi's No. 16 national placement and No. 6 San Francisco placement underscore its growing presence both across the country and in its home city. This year's list features companies across a range of industries, including companies like Mercor, Anthropic, and Perplexity.

Corgi is building an AI-native, full-stack commercial insurance carrier designed for modern businesses. By bringing technology and automation into the insurance lifecycle, the company aims to make coverage faster, smarter and more accessible while expanding its offerings across industries and emerging risks.

Beyond insurance, Corgi has developed a distinctive presence in the startup community through its Corgi Cafes, branded buses and community gatherings. These spaces bring founders, operators and builders together and reflect the company's approach to building relationships with the businesses it serves.

The recognition follows Corgi's inclusion in Fast Company's 2026 Best Workplaces for Innovators in North America list, further highlighting the company's growing profile in technology and insurance.

The full LinkedIn Top Startups 2026 list is available at: https://www.linkedin.com/pulse/linkedin-top-startups-2026-50-us-companies-rise-linkedin-news-pzfoe/

About Corgi Insurance

Corgi is an AI-native insurance carrier built for high-growth companies. The company combines proprietary underwriting technology, in-house claims handling, and modern insurance infrastructure to deliver coverage built for the way businesses operate today.

Media Contact

Erika Lee

Corgi Insurance

[email protected]

SOURCE Corgi

Share this article